Efficacy, Safety, and Tolerability of COMP360 in Participants With TRD

Clinical trial NCT05624268 · COMPLETED

Trial details

NCT number: NCT05624268
Sponsor: COMPASS Pathways
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Treatment Resistant Depression

Start date: 2023-01-24
Primary completion: 2025-05-28
Enrollment: 258

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.